Correspondence 0001493152-24-035438 from IMPACT BIOMEDICAL INC. (IBO)

IMPACT BIOMEDICAL INC.
Date: Sept. 9, 2024 · CIK: 0001834105 · Accession: 0001493152-24-035438

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-275062

Date

Sept. 9, 2024

Author

Chief

Form

CORRESP

Company

IMPACT BIOMEDICAL INC.

Letter

Impact BioMedical Inc.

Broadfield Blvd., Suite 130

Houston, TX 77084

Tel: (585) 325-3610

September 9, 2024

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

F. Street, N.E.

Washington, D.C. 20549

Attention: Daniel Crawford

Re: Impact BioMedical Inc.

Registration Statement on Form S-1

File No. 333-275062

Ladies and Gentlemen:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 4:00 p.m., Eastern Time on September 11, 2024, or as soon thereafter as practicable.

Please contact Darrin M. Ocasio, Esq. of Sichenzia Ross Ference Carmel LLP at (917) 848-6325, as soon as the Registration Statement has been declared effective, or if you have any other questions or concerns regarding this matter.

Very
truly yours,
IMPACT
BIOMEDICAL INC.

Show Raw Text

CORRESP
1
filename1.htm

Impact
BioMedical Inc.

1400
Broadfield Blvd., Suite 130

Houston,
TX 77084

Tel:
(585) 325-3610

September
9, 2024

VIA
EDGAR

United
States Securities and Exchange Commission

Division
of Corporation Finance

Office
of Life Sciences

100
F. Street, N.E.

Washington,
D.C. 20549

Attention:
Daniel Crawford

    Re:
                                            Impact BioMedical Inc.

    Registration
    Statement on Form S-1

    File
    No. 333-275062

Ladies
and Gentlemen:

Pursuant
to Rule 461 promulgated under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date for
the Registration Statement referred to above be accelerated so that it will be declared effective at 4:00 p.m., Eastern Time on September
11, 2024, or as soon thereafter as practicable.

Please
contact Darrin M. Ocasio, Esq. of Sichenzia Ross Ference Carmel LLP at (917) 848-6325, as soon as the Registration Statement has been
declared effective, or if you have any other questions or concerns regarding this matter.

    Very
    truly yours,

    IMPACT
    BIOMEDICAL INC.

    By:

    /s/
    Frank D. Heuszel

    Frank
    D. Heuszel

    Chief
    Executive Officer

SecProbe.io